KS106
KS106 is a potent ALDH inhibitor with IC50s of 334, 2137, 360 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS106 induces apoptosis and cell cycle arrest at the G2/M phase[1].
Product Specifications
CAS Number
[2408477-50-7]
UNSPSC
12352005
Target
Aldehyde Dehydrogenase (ALDH) ; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ks106.html
Purity
99.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N=C(SCC1=CC=C(C=C1)CN2C(C(C3=CC(C(F)(F)F)=CC=C32)=O)=O)N.Br
Molecular Formula
C18H15BrF3N3O2S
Molecular Weight
474.29
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALDH1; ALDH2; ALDH3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TCR, alpha, beta (T Cell Receptor, T-cell Receptor beta-1 Chain C Region, TRBC1, T-cell Receptor alpha Chain C Region, TRAC, TCRA) (APC)
TCR, alpha, beta (T Cell Receptor, T-cell Receptor beta-1 Chain C Region, TRBC1, T-cell Receptor alpha Chain C Region, TRAC, TCRA) (APC)
Rat TNFRSF9 (Tumor Necrosis Factor Receptor Superfamily, Member 9) ELISA Kit